Dietary precursors and cardiovascular disease: A Mendelian randomization study

被引:3
|
作者
Jing, Wangwei [1 ]
Huang, Shushi [1 ]
Xiang, Pingping [1 ]
Huang, Jiniu [1 ]
Yu, Hong [2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Cardiol, Hangzhou, Peoples R China
[2] Zhejiang Univ Sch Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
dietary precursors; cardiovascular disease; Mendelian randomization (MR) analysis; choline; carnitine; HEART-FAILURE; CHOLINE; INSTRUMENTS; HEALTH; METABOLISM; INFLAMMATION; DYSFUNCTION; PLEIOTROPY; CARNITINE; IMPACT;
D O I
10.3389/fcvm.2023.1061119
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe Dietary precursor has been identified as a contributor in the development of cardiovascular disease. However, it is inconsistent if dietary precursors could affect the process of cardiovascular disease. MethodsHere we performed Mendelian randomization (MR) analysis of the data from genome-wide association study of European ancestry to evaluate the independent effects of three dietary precursors on cardiovascular disease (CVD), myocardial infarction (MI), heart failure (HF), atrial fibrillation (AF), and valvular disease (VHD). Inverse variance weighting method was used for the MR estimation. Sensitivity was determined by MR-PRESSO analysis, weighted median analysis, MR-Egger analysis, and Leave-one-out analysis. ResultsWe found that elevated choline level had a causal relationship with VHD [odds ratio (OR) = 1.087, 95% confidence interval (CI), 1.003-1.178, P = 0.041] and MI (OR = 1.250, 95% CI, 1.041-1.501, P = 0.017) by single-variable MR analysis. Furthermore, elevated carnitine level was associated with MI (OR = 5.007, 95% CI, 1.693-14.808, P = 0.004) and HF (OR = 2.176, 95% CI, 1.252-3.780, P = 0.006) risk. In addition, elevated phosphatidylcholine level can increase the risk of MI (OR = 1.197, 95% CI, 1.026-1.397, P = 0.022). ConclusionOur data show that choline increases VHD or MI risk, carnitine increases the risk of MI or HF, and phosphatidylcholine increases HF risk. These findings suggest the possibility that decrease in choline level in circulation may be able to reduce overall VHD or MI risk, reduce in carnitine level could be decrease MI and HF risks as well as decrease in phosphatidylcholine could reduce MI risk.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Cannabis use and atherosclerotic cardiovascular disease: a Mendelian randomization study
    de La Harpe, Roxane
    Schoeler, Tabea
    Thorball, Christian W.
    Thomas, Aurelien
    Kutalik, Zoltan
    Vaucher, Julien
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [22] Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study
    Yuan, Shuai
    Mason, Amy M.
    Carter, Paul
    Burgess, Stephen
    Larsson, Susanna C.
    BMC MEDICINE, 2021, 19 (01)
  • [23] Systemic lupus erythematosus and cardiovascular disease: A Mendelian randomization study
    Kerns, Sophia
    Owen, Katherine A.
    Kain, Jessica
    Lipsky, Peter E.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Commentary: Mendelian randomization, testosterone, and cardiovascular disease
    Gong, Jian
    Zubair, Niha
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (02) : 621 - 622
  • [25] Mendelian randomization: Its impact on cardiovascular disease
    Kawashiri, Masa-aki
    Tada, Hayato
    Nomura, Akihiro
    Yamagishi, Masakazu
    JOURNAL OF CARDIOLOGY, 2018, 72 (3-4) : 307 - 313
  • [26] Dietary factors and Alzheimer's disease risk: a Mendelian randomization study
    Meng, Qi
    Chen, Chen
    Zhu, Mingfang
    Huang, Yue
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01) : 261
  • [27] Mendelian randomization study on insulin resistance and risk of hypertension and cardiovascular disease
    Fangfang Zhang
    Zhimin Yu
    Scientific Reports, 14
  • [28] Narcolepsy and cardiovascular disease: A two-sample Mendelian randomization study
    Tao, Yanmin
    Luo, Jingsong
    Xu, Yaxin
    Wang, Hongyan
    Tian, Jing
    Yang, Shenbi
    Yu, Kexin
    Peng, Sihan
    Zhang, Xiangeng
    SLEEP MEDICINE, 2024, 113 : 6 - 12
  • [29] Effects of menstrual disorders and dysmenorrhea on cardiovascular disease: a Mendelian randomization study
    Lai, Sijia
    Jin, Qiubai
    Wang, Dayang
    Li, Tianli
    Wang, Xian
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [30] Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study
    Xia, Juan
    Guo, Chunyue
    Liu, Kuo
    Xie, Yunyi
    Cao, Han
    Peng, Wenjuan
    Sun, Yanyan
    Liu, Xiaohui
    Li, Bingxiao
    Zhang, Ling
    LIPIDS IN HEALTH AND DISEASE, 2021, 20 (01)